Mayo clinic tests new hope for rare, severe skin disease
NCT ID NCT07497620
Summary
This small study is testing if an existing medication, Bimzelx, can help adults with a rare and severe skin condition called Pityriasis Rubra Pilaris (PRP). The goal is to see if the drug can significantly clear skin lesions and improve patients' quality of life over 24-28 weeks. It's an early, exploratory trial with only 12 participants to gather initial evidence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITYRIASIS RUBRA PILARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
Conditions
Explore the condition pages connected to this study.